Daruka Mahadevan MD
Associate Professor, Medicine, University of Arizona College of Medicine
Join to View Full Profile
7979 Wurzbach RdSan Antonio, TX 78229
Phone+1 210-450-1143
Fax+1 210-450-0407
Dr. Mahadevan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2000 - 2002
University of ConnecticutResidency, Internal Medicine, 1994 - 1997
Guy's, King's and St Thomas' School of Medical EducationClass of 1990
Certifications & Licensure
TX State Medical License 2020 - 2027
AZ State Medical License 2002 - 2021
TN State Medical License 2012 - 2017
MS State Medical License 2013 - 2016
CT State Medical License 1998 - 2003
American Board of Internal Medicine Medical Oncology
Clinical Trials
- S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 Sep 01
- Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
- Study of PWT33597 Mesylate in Subjects With Advanced Malignancies Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsPolyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging Treatments.Patrick J Conway, Jonathan Dao, Dmytro Kovalskyy, Daruka Mahadevan, Eloise Dray
Molecular Cancer Therapeutics. 2024-05-02 - Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research.Gregory A Vidal, Patricia Chalela, Andrea N Curry, Bassel El-Rayes, Balazs Halmos
Contemporary Clinical Trials. 2024-02-01 - (HER2) amplifications and co-occurringalterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, Victoria M Raymond, Andrea Wang-Gillam
Frontiers in Oncology. 2024-01-01
Journal Articles
- Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase 1b StudyKaren Kelly, Montaser Shaheen, Shadia Jalal, Daruka Mahadevan, Clinical Cancer Research
- Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/vincristine in Relapsed/refractory Aggressive B-cell LymphomaDaniel Persky, Soham Puvvada, Catherine Spier, Gregory Monohan, Ari VanderWalde, Daruka Mahadevan, Clinical Cancer Research
Press Mentions
Researchers Look to Bring New Blood Tests for Cancer to MarketMay 26th, 2019
Immunotherapy—Cancer's New FrontierApril 5th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
